相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。AAV-directed muscular dystrophy gene therapy
Ying Tang et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2010)
Coordinated patterns of gene expressions for adult muscle build-up in transgenic mice expressing myostatin propeptide
Baoping Zhao et al.
BMC GENOMICS (2009)
Gene therapy for muscular dystrophy: current progress and future prospects
Capucine Trollet et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2009)
In vivo comparison of 2′-O-methyl phosphorothioate and morpholino antisense oligonucleotides for Duchenne muscular dystrophy exon skipping
Hans A. Heemskerk et al.
JOURNAL OF GENE MEDICINE (2009)
Diagnosis and new treatments in muscular dystrophies
A. Y. Manzur et al.
POSTGRADUATE MEDICAL JOURNAL (2009)
Local restoration of dystrophin expression with the morpholino oligomer AVI-4658 in Duchenne muscular dystrophy: a single-blind, placebo-controlled, dose-escalation, proof-of-concept study. (vol 8, pg 918, 2009)
M. Kinali et al.
LANCET NEUROLOGY (2009)
Guidelines for Antisense Oligonucleotide Design and Insight Into Splice-modulating Mechanisms
Annemieke Aartsma-Rus et al.
MOLECULAR THERAPY (2009)
SINGLE MUSCLE FIBER CONTRACTILE PROPERTIES IN ADULTS WITH MUSCULAR DYSTROPHY TREATED WITH MYO-029
Lisa S. Krivickas et al.
MUSCLE & NERVE (2009)
Molecular, cellular and physiological investigation of myostatin propeptide-mediated muscle growth in adult mice
Antonios Matsakas et al.
NEUROMUSCULAR DISORDERS (2009)
RNA-targeting approaches for neuromuscular diseases
Florence Le Roy et al.
TRENDS IN MOLECULAR MEDICINE (2009)
Local restoration of dystrophin expression with the morpholino oligomer AVI-4658 in Duchenne muscular dystrophy: a single-blind, placebo-controlled, dose-escalation, proof-of-concept study
Maria Kinali et al.
LANCET NEUROLOGY (2009)
Diagnosis and new treatments in muscular dystrophies
A. Y. Manzur et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2009)
A phase I/II trial of MYO-029 in adult subjects with muscular dystrophy
Kathryn R. Wagner et al.
ANNALS OF NEUROLOGY (2008)
Myostatin signals through Pax7 to regulate satellite cell self-renewal
Craig McFarlane et al.
EXPERIMENTAL CELL RESEARCH (2008)
Myostatin propeptide gene delivery by adeno-associated virus serotype 8 vectors enhances muscle growth and ameliorates dystrophic phenotypes in mdx mice
Chunping Qiao et al.
HUMAN GENE THERAPY (2008)
Myostatin directly regulates skeletal muscle fibrosis
Zhao Bo Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Proteomic Identification and Functional Validation of Activins and Bone Morphogenetic Protein 11 as Candidate Novel Muscle Mass Regulators
Tatyana A. Souza et al.
MOLECULAR ENDOCRINOLOGY (2008)
Myostatin antisense RNA-mediated muscle growth in normal and cancer cachexia mice
C-M Liu et al.
GENE THERAPY (2008)
Local dystrophin restoration with antisense oligonucleotide PRO051
Judith C. van Deutekom et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Quadrupling Muscle Mass in Mice by Targeting TGF-β Signaling Pathways
Se-Jin Lee
PLOS ONE (2007)
Cellular senescence in human myoblasts is overcome by human telomerase reverse transcriptase and cyclin-dependent kinase 4: consequences in aging muscle and therapeutic strategies for muscular dystrophies
Chun-Hong Zhu et al.
AGING CELL (2007)
Myostatin short interfering hairpin RNA gene transfer increases skeletal muscle mass
Thomas R. Magee et al.
JOURNAL OF GENE MEDICINE (2006)
Entries in the Leiden Duchenne muscular dystrophy mutation database: An overview of mutation types and paradoxical cases that confirm the reading-frame rule
Annemieke Aartsma-Rus et al.
MUSCLE & NERVE (2006)
A mutation creating a potential illegitimate microRNA target site in the myostatin gene affects muscularity in sheep
Alex Clop et al.
NATURE GENETICS (2006)
Myostatin imposes reversible quiescence on embryonic muscle precursors
H Amthor et al.
DEVELOPMENTAL DYNAMICS (2006)
Regulation of muscle growth by multiple ligands signaling through activin type II receptors
SJ Lee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Myostatin propeptide-mediated amelioration of dystrophic pathophysiology
S Bogdanovich et al.
FASEB JOURNAL (2005)
Functional analysis of 114 exon-internal AONs for targeted DMD exon skipping: Indication for steric hindrance of SR protein binding sites
A Aartsma-Rus et al.
OLIGONUCLEOTIDES (2005)
Targeted exon skipping in transgenic hDMD mice:: A model for direct preclinical screening of human-specific antisense oligonucleotides
M Bremmer-Bout et al.
MOLECULAR THERAPY (2004)
Antisense-induced multiexon skipping for Duchenne muscular dystrophy makes more sense
A Aartsma-Rus et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2004)
Brief report -: Myostatin mutation associated with gross muscle hypertrophy in a child
M Schuelke et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Myostatin signals through a transforming growth factor β-like signaling pathway to block adipogenesis
A Rebbapragada et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
Myostatin negatively regulates satellite cell activation and self-renewal
S McCroskery et al.
JOURNAL OF CELL BIOLOGY (2003)
Therapeutic antisense-induced exon skipping in cultured muscle cells from six different DMD patients
A Aartsma-Rus et al.
HUMAN MOLECULAR GENETICS (2003)
Myostatin inhibits myoblast differentiation by down-regulating MyoD expression
B Langley et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Functional improvement of dystrophic muscle by myostatin blockade
S Bogdanovich et al.
NATURE (2002)
Improved antisense oligonucleotide induced exon skipping in the mdx mouse model of muscular dystrophy
CJ Mann et al.
JOURNAL OF GENE MEDICINE (2002)
Targeted exon skipping as a potential gene correction therapy for Duchenne muscular dystrophy
A Aartsma-Rus et al.
NEUROMUSCULAR DISORDERS (2002)
Myostatin regulates cell survival during C2C12 myogenesis
R Ríos et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)
Myostatin, a negative regulator of muscle growth, functions by inhibiting myoblast proliferation
M Thomas et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)